Today: 1 May 2026
Browse Category

Mergers and Acquisitions 24 December 2025 - 20 January 2026

Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

Netflix flips to an all-cash $82.7 billion Warner Bros. Discovery bid as Paramount clock ticks

Netflix switched to an all-cash $27.75-per-share bid for Warner Bros. Discovery’s studio and streaming units, keeping the total value at $82.7 billion. The move comes just before Paramount Skydance’s $30-per-share tender offer expires Jan. 21. Warner set a $1.33–$6.86 per-share valuation for the Discovery Global spinoff. Netflix shares rose 1.3% in premarket trading; Warner slipped.
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching

Kenvue shares rose 0.4% to $17.08 in mid-morning trading after Kimberly-Clark filed new deal documents with U.S. regulators. The stock remains about 5% below the value implied by the pending cash-and-stock takeover. Kenvue shareholders are set to vote on the deal Jan. 29. The transaction’s value fluctuates with Kimberly-Clark’s share price.
Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

Netflix stock slips as all-cash Warner Bros bid talk swirls, with earnings days away

Netflix shares fell 1.6% Wednesday as investors weighed reports it may switch to an all-cash bid for Warner Bros Discovery’s studio and streaming assets, valued at $82.7 billion. Paramount Skydance, offering $108.4 billion for all of Warner Bros, escalated its challenge with a lawsuit and board nominations. Warner Bros dismissed the lawsuit as meritless. Netflix’s quarterly results are due January 20.
Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol stock rises as Barclays, Citi and Truist lift targets after CommScope deal closes

Amphenol shares rose 2.2% to $148.28 Tuesday, bucking a broader market decline after finalizing its $10.5 billion acquisition of CommScope’s CCS business. Analysts at Barclays, Citi, and Truist raised price targets, citing expected sales growth and stronger demand. The company projects CCS will add $4.1 billion in 2026 sales and $0.15 to EPS, excluding costs. Quarterly earnings are due Jan. 28.
GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

GSK stock in focus: JPMorgan healthcare agenda, merger chatter and key dates for investors

GSK shares slipped 0.03% to 1,885.5 pence in early London trading Monday, as investors awaited the company’s appearance at the J.P. Morgan Healthcare Conference in San Francisco on Tuesday. GSK’s ADRs closed up 0.3% in the U.S. at $50.39. Traders are watching for updates ahead of GSK’s full-year results due February 4.
Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck stock dips after $32 billion Revolution Medicines talks report, with Gardasil and Keytruda in focus

Merck shares fell 0.4% to $110.53 after reports it is in talks to acquire Revolution Medicines for up to $32 billion. The company faces new scrutiny over its Gardasil and RotaTeq vaccines after U.S. policy changes, with analysts estimating a $2 billion annual revenue impact. Wolfe Research upgraded Merck, citing progress on a subcutaneous version of Keytruda.
D-Wave Quantum stock (QBTS) slides after $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum stock (QBTS) slides after $550 million Quantum Circuits deal puts dilution in focus

D-Wave Quantum shares fell 3.4% to $30.20 after announcing a $550 million deal to acquire Quantum Circuits, split between $250 million cash and $300 million in stock. The agreement uses a VWAP collar to set share count and requires antitrust and NYSE approval. The deal aims to bring superconducting gate-model systems to market in 2026. Trading volume reached 36.5 million shares.
Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck stock slips after Cidara tender offer; $9 billion R&D hit and HPV schedule shift in focus

Merck shares slipped 0.3% to $108.59 after it completed its tender offer for Cidara Therapeutics and expects to finalize the $9.2 billion acquisition later Wednesday. The deal will add about $9 billion to 2026 R&D expenses and reduce earnings per share by 30 cents in the first year. Merck also began a Phase 3 lung-cancer trial of calderasib with Keytruda QLEX. U.S. officials updated HPV and rotavirus vaccine guidance this week.
US stock market: Vistra stock pops in premarket on $4.7B Cogentrix deal amid AI power-demand boom

US stock market: Vistra stock pops in premarket on $4.7B Cogentrix deal amid AI power-demand boom

Vistra shares rose 4.4% to $170.17 premarket Tuesday after agreeing to buy Cogentrix Energy from Quantum Capital Group in a deal valued at $4.7 billion. The acquisition adds 5.5 gigawatts of natural gas generation across key U.S. markets and is expected to close in mid-to-late 2026. Vistra said the deal should boost per-share cash flow starting in 2027.
BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel shares jumped 20.6% to A$29.48 after SGH and Steel Dynamics made a non-binding A$30-per-share takeover offer. The proposal, received Dec. 12, is subject to due diligence, exclusivity, and other conditions. BlueScope’s board is reviewing the bid against its own valuation. The company previously rejected lower offers, citing execution risks.
Uber stock slips as SpotHero acquisition-talk report emerges in year-end trade

Uber stock slips as SpotHero acquisition-talk report emerges in year-end trade

Uber shares slipped 0.3% to $81.87 after a report said the company has held talks to acquire parking app SpotHero, which was last valued at about $290 million. SpotHero operates in over 400 North American cities. Traders await confirmation of the talks and Uber’s next earnings report, expected Feb. 4. Lyft rose 0.2% while DoorDash fell 0.2% in afternoon trading.
Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax stock drops today as ABVX traders trim Eli Lilly takeover bets into year-end

Abivax’s U.S.-listed shares fell 3.8% to $133.04 late Wednesday morning, reversing part of a recent surge driven by takeover speculation and index inclusion. Trading volume reached about 348,000 shares as the stock swung between $132.13 and $140.25. Investors await updates on strategic interest and new data for obefazimod, the company’s lead drug candidate.
Coforge’s $2.35 billion Encora deal tops India’s stocks-to-watch list for Dec. 29

Coforge’s $2.35 billion Encora deal tops India’s stocks-to-watch list for Dec. 29

Coforge agreed to acquire U.S.-based Encora for $2.35 billion and will raise up to $550 million via a share sale to fund the deal. Punjab National Bank reported a 24.34 billion-rupee fraud to regulators. Timex Group India’s promoter plans to sell up to 8.93% on Dec. 29–30. GIFT Nifty futures rose 40 points to 26,100 ahead of Monday’s open.
Ondas Holdings (NASDAQ: ONDS) Stock News Today: Defense-Drone Contracts, M&A Momentum, and Fresh Analyst Targets in a Thin Holiday Market

Ondas Holdings (NASDAQ: ONDS) Stock News Today: Defense-Drone Contracts, M&A Momentum, and Fresh Analyst Targets in a Thin Holiday Market

Ondas Holdings Inc. shares fell about 6% to $8.56 by early afternoon Friday, trading on heavy volume over 24 million shares. The drop comes as small-cap stocks lag in a quiet, post-holiday session, with large-cap and tech indexes little changed. Ondas recently announced a major government contract for an autonomous border-protection drone system, with an initial order expected in January 2026.
Zeta Global (ZETA) Stock Today: Marigold Deal, AI-Agent Momentum, and Wall Street Targets as Markets Reopen After Christmas

Zeta Global (ZETA) Stock Today: Marigold Deal, AI-Agent Momentum, and Wall Street Targets as Markets Reopen After Christmas

Zeta Global Holdings traded near $19.12 late Friday morning, little changed after opening at $19.05. The stock showed muted movement as U.S. markets reopened post-Christmas with light volume. Investors continue to weigh Zeta’s recent $325 million Marigold acquisition and raised guidance ahead of CES 2026.
AI Stocks Today (Dec. 25, 2025): Nvidia’s Groq Deal, Snowflake’s M&A Talks, UiPath’s Index Boost, and Meta’s WhatsApp AI Clash

AI Stocks Today (Dec. 25, 2025): Nvidia’s Groq Deal, Snowflake’s M&A Talks, UiPath’s Index Boost, and Meta’s WhatsApp AI Clash

Nvidia has secured a non-exclusive license to Groq’s AI inference chip technology and is hiring Groq’s founder, president, and key engineers, Reuters reports. Groq will continue operating independently under a new CEO. Snowflake is reportedly in talks to acquire Observe for about $1 billion, according to Investors.com, in what would be its largest deal to date.
AI Stocks Today (Dec. 24, 2025, 5:02 p.m. ET): Nvidia’s Reported $20B Groq Deal, Snowflake M&A Talk, and Wall Street’s 2026 AI Outlook

AI Stocks Today (Dec. 24, 2025, 5:02 p.m. ET): Nvidia’s Reported $20B Groq Deal, Snowflake M&A Talk, and Wall Street’s 2026 AI Outlook

Nvidia agreed to acquire AI chip startup Groq for $20 billion in cash, Reuters reported Wednesday, citing CNBC. The S&P 500 and Dow closed at record highs after an early Christmas Eve session, lifted by renewed demand for tech and AI stocks and expectations of Fed rate cuts in 2026. Trading volumes were thin ahead of the holiday.
1 2 3 4 7

Stock Market Today

  • Australian Shares Expected to Rise as US Markets Hit Record Highs and Corporate Earnings Impress
    May 1, 2026, 1:25 AM EDT. Australian sharemarket futures surged 131 points to 8,677, reflecting optimism after Wall Street's record-breaking session where the Dow Jones rose 1.62% and the S&P 500 posted its strongest monthly gain since November 2020. Persistent gains in tech and industrial giants, including Atlassian, Apple, and Caterpillar, bolstered investor confidence. Brent crude oil briefly hit $126 a barrel amid Middle East tensions before settling down slightly. The Australian dollar strengthened to 72 US cents, with Bitcoin modestly up. Locally, attention shifts to March producer price indexes from the Australian Bureau of Statistics, while US economic data showed 2% GDP growth in Q1 2026 alongside rising inflation at 3.5%. The mix of robust earnings and macroeconomic signals sets the stage for a rally in Australian equities.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 01.05.2026

1 May 2026
LIVEMarkets rolling coverageStarted: May 1, 2026, 12:00 AM EDTUpdated: May 1, 2026, 1:31 AM EDT Australian Shares Expected to Rise as US Markets Hit Record Highs and Corporate Earnings Impress May 1, 2026, 1:25 AM EDT. Australian sharemarket futures surged 131 points to 8,677, reflecting optimism after Wall Street's record-breaking session where the Dow Jones rose 1.62% and the S&P 500 posted its strongest monthly gain since November 2020. Persistent gains in tech and industrial giants, including Atlassian, Apple, and Caterpillar, bolstered investor confidence. Brent crude oil briefly hit $126 a barrel amid Middle East tensions before settling down slightly.
Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

Sandisk Stock Falls After Blowout Q3 Earnings as AI Storage Rally Hits a High Bar

1 May 2026
Sandisk shares dropped about 6% in after-hours trading Thursday despite reporting fiscal Q3 revenue of $5.95 billion, up 251% from a year earlier, and net income of $3.62 billion. The company announced a $6 billion buyback and forecast Q4 revenue of up to $8.25 billion. Gross margin rose to 78.4%. Shares had closed at $1,096.51 before slipping to about $1,030.
Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

Apple Stock Slips After Earnings Beat as iPhone Supply Snag Clouds $100 Billion Buyback

1 May 2026
Apple reported fiscal Q2 revenue of $111.2 billion and earnings of $2.01 per share, beating analyst estimates. The board approved a $100 billion share buyback and raised the dividend. Shares fell about 1% after hours as iPhone sales missed forecasts and chip supply remained tight. Investors are watching for clarity on AI strategy and the upcoming CEO transition to John Ternus.
Go toTop